Cargando…

Frequencies of maternal red blood cell alloantibodies in Port Harcourt, Nigeria

BACKGROUND: Alloantibodies of clinical importance can cause transfusion reactions or hemolytic disease of the fetus and newborn (HDFN). The frequencies of these antibodies have not been reported in our locality. AIMS: To determine the frequency of occurrence of alloantibodies among pregnant women in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeremiah, Zaccheaus A., Mordi, Augustina, Buseri, Fiekumo I., Adias, Teddy. C.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082715/
https://www.ncbi.nlm.nih.gov/pubmed/21572714
http://dx.doi.org/10.4103/0973-6247.75987
_version_ 1782202318623604736
author Jeremiah, Zaccheaus A.
Mordi, Augustina
Buseri, Fiekumo I.
Adias, Teddy. C.
author_facet Jeremiah, Zaccheaus A.
Mordi, Augustina
Buseri, Fiekumo I.
Adias, Teddy. C.
author_sort Jeremiah, Zaccheaus A.
collection PubMed
description BACKGROUND: Alloantibodies of clinical importance can cause transfusion reactions or hemolytic disease of the fetus and newborn (HDFN). The frequencies of these antibodies have not been reported in our locality. AIMS: To determine the frequency of occurrence of alloantibodies among pregnant women in Port Harcourt, Nigeria. SETTINGS AND DESIGN: This is a prospective study, which was carried out in the Braithwaite Memorial Specialist Hospital, Port Harcourt, Nigeria. MATERIALS AND METHODS: Screening and identification of red blood cell alloantibodies was done on the sera of 500 pregnant women using the DiaMed, DiaCell, and DiaPanel reagents (Cressier, Switzerland). ABO and Rh blood groups were done using antisera bought from Biotec (Ipswich, UK). RESULTS: Alloantibodies were identified in the serum of 17 of the 500 (3.4%) pregnant women. The specificity of the antibodies was as follows: anti-C 6 (1.2%), anti-E 3 (0.6%), anti-Jsb 3 (0.6%), and anti-K 5 (1.0%). No anti-D was identified despite 8.6% of the study population being Rhesus D (Rh D) negative. The distribution of the antibodies was found to be independent of the blood groups of the participants (χ(2) = 4.050, P = 0.670). Blood group O constituted the highest percentage (48.0%). CONCLUSION: This study has identified the presence of non-Rh D antibodies to the proportion of 3.4%. Rh D antibody was absent in this population irrespective of the relatively high percentage of Rh D negative women. There is a need to determine the actual risk these antibodies may pose to the antenatal women and to include antibody screening and identification in routine antenatal care.
format Text
id pubmed-3082715
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30827152011-05-13 Frequencies of maternal red blood cell alloantibodies in Port Harcourt, Nigeria Jeremiah, Zaccheaus A. Mordi, Augustina Buseri, Fiekumo I. Adias, Teddy. C. Asian J Transfus Sci Original Article BACKGROUND: Alloantibodies of clinical importance can cause transfusion reactions or hemolytic disease of the fetus and newborn (HDFN). The frequencies of these antibodies have not been reported in our locality. AIMS: To determine the frequency of occurrence of alloantibodies among pregnant women in Port Harcourt, Nigeria. SETTINGS AND DESIGN: This is a prospective study, which was carried out in the Braithwaite Memorial Specialist Hospital, Port Harcourt, Nigeria. MATERIALS AND METHODS: Screening and identification of red blood cell alloantibodies was done on the sera of 500 pregnant women using the DiaMed, DiaCell, and DiaPanel reagents (Cressier, Switzerland). ABO and Rh blood groups were done using antisera bought from Biotec (Ipswich, UK). RESULTS: Alloantibodies were identified in the serum of 17 of the 500 (3.4%) pregnant women. The specificity of the antibodies was as follows: anti-C 6 (1.2%), anti-E 3 (0.6%), anti-Jsb 3 (0.6%), and anti-K 5 (1.0%). No anti-D was identified despite 8.6% of the study population being Rhesus D (Rh D) negative. The distribution of the antibodies was found to be independent of the blood groups of the participants (χ(2) = 4.050, P = 0.670). Blood group O constituted the highest percentage (48.0%). CONCLUSION: This study has identified the presence of non-Rh D antibodies to the proportion of 3.4%. Rh D antibody was absent in this population irrespective of the relatively high percentage of Rh D negative women. There is a need to determine the actual risk these antibodies may pose to the antenatal women and to include antibody screening and identification in routine antenatal care. Medknow Publications 2011-01 /pmc/articles/PMC3082715/ /pubmed/21572714 http://dx.doi.org/10.4103/0973-6247.75987 Text en © Asian Journal of Transfusion Science http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jeremiah, Zaccheaus A.
Mordi, Augustina
Buseri, Fiekumo I.
Adias, Teddy. C.
Frequencies of maternal red blood cell alloantibodies in Port Harcourt, Nigeria
title Frequencies of maternal red blood cell alloantibodies in Port Harcourt, Nigeria
title_full Frequencies of maternal red blood cell alloantibodies in Port Harcourt, Nigeria
title_fullStr Frequencies of maternal red blood cell alloantibodies in Port Harcourt, Nigeria
title_full_unstemmed Frequencies of maternal red blood cell alloantibodies in Port Harcourt, Nigeria
title_short Frequencies of maternal red blood cell alloantibodies in Port Harcourt, Nigeria
title_sort frequencies of maternal red blood cell alloantibodies in port harcourt, nigeria
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082715/
https://www.ncbi.nlm.nih.gov/pubmed/21572714
http://dx.doi.org/10.4103/0973-6247.75987
work_keys_str_mv AT jeremiahzaccheausa frequenciesofmaternalredbloodcellalloantibodiesinportharcourtnigeria
AT mordiaugustina frequenciesofmaternalredbloodcellalloantibodiesinportharcourtnigeria
AT buserifiekumoi frequenciesofmaternalredbloodcellalloantibodiesinportharcourtnigeria
AT adiasteddyc frequenciesofmaternalredbloodcellalloantibodiesinportharcourtnigeria